Found: 13
Select item for more details and to access through your institution.
Gilteritinib with or without venetoclax for relapsed/refractory FLT3‐mutated acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 932, doi. 10.1111/bjh.19548
- By:
- Publication type:
- Article
How we treat older patients with acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 682, doi. 10.1111/bjh.16701
- By:
- Publication type:
- Article
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 790, doi. 10.1002/ajh.26190
- By:
- Publication type:
- Article
Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effect.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 9, p. 794, doi. 10.1093/ajhp/zxab043
- By:
- Publication type:
- Article
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 9, p. 2001, doi. 10.1007/s00277-022-04895-8
- By:
- Publication type:
- Article
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 8, p. 1719, doi. 10.1007/s00277-022-04883-y
- By:
- Publication type:
- Article
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Venetoclax‐based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 365, doi. 10.1111/ejh.14015
- By:
- Publication type:
- Article
Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3‐ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 64, doi. 10.1111/ejh.13518
- By:
- Publication type:
- Article
Midostaurin in Combination with Intensive Chemotherapy is Safe and Associated with Improved Remission Rates and Higher Transplantation Rates in First Remission-A Multi-Center Historical Control Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S208, doi. 10.1016/j.clml.2019.07.072
- By:
- Publication type:
- Article
Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 10, p. 1805, doi. 10.1093/cid/ciz194
- By:
- Publication type:
- Article
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E3, doi. 10.1002/ajh.25651
- By:
- Publication type:
- Article